|   | ![]() Your Search for Kaposi's Sarcoma matched 1000 Documents (Page 1 of 34). You may want to refine your search. Results Indexed by relevance. |
| 1. |
FRANCE: Low CD4 Cell Count Elevates Cancer Risk in Patients with HIV (100%) Abstract: Having a more compromised immune system is the biggest risk factor for both AIDS-defining and non-AIDS-defining cancers in HIV patients, a new study by French researchers finds. Noting that the relative roles of immunodeficiency, HIV viral load and cART [combination antiretroviral therapy] in the onset of individual ca ... http://www.aegis.com/news/ads/2009/ad091745.html File Name: ad091745.html, Size: 10KB, Last Modified: Thursday, October 08, 2009 at 3:00:00 PM |
| 2. |
AEGiS-GMHC: KSHV Study in HIV-negative Individuals (100%) Abstract: Columbia University College of Physicians and Surgeons is performing a study of Kaposi s sarcoma-associated herpesvirus (KSHV/HHV-8). This recently discovered virus has been found to be associated with clinical forms of Kaposi s sarcoma, including the type that occurs in HIV-negative individuals. The laboratory of Drs. ... http://www.aegis.com/pubs/gmhc/1998/gm120204.html File Name: gm120204.html, Size: 7KB, Last Modified: Thursday, May 21, 2009 at 9:28:18 PM |
| 3. |
AEGiS-GMHC: Common Alternative Therapies: Shark Cartilage (100%) Abstract: Shark cartilage is rich in an angiogenesis inhibiting protein called Cartilage- derived Inhibitor. Angiogenesis is the process whereby new blood vessels are formed to feed cancer, particularly solid tumors, such as Kaposi s sarcoma.[1, 2] In June 1992, a small community-based study of shark cartilage as a monotherapy t ... http://www.aegis.com/pubs/gmhc/1993/gm071123.html File Name: gm071123.html, Size: 7KB, Last Modified: Thursday, May 21, 2009 at 9:28:13 PM |
| 4. |
AEGiS-GMHC: TREATMENT BRIEFS: Promising CD8 Therapy Plus IL-2 (100%) Abstract: Activists are excited about reports of a promising anti-HIV and Kaposi s sarcoma therapy, which reactivates T8 cells. The treatment uses a device, developed by Applied Immune Science, which removes blood from the patient, activates T8 cells and infuses the blood back into the body along with Interleukin-2. In Phase I t ... http://www.aegis.com/pubs/gmhc/1992/gm060207.html File Name: gm060207.html, Size: 7KB, Last Modified: Thursday, May 21, 2009 at 9:28:11 PM |
| 5. |
AEGiS-AIDSWeekly: HIV/AIDS Cancer Therapy: New HIV/AIDS cancer therapy study findings have been reported from University of North Carolina, Center for AIDS Research (100%) Abstract: Researchers detail in "Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy," new data in HIV/AIDS cancer. "The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) is associated with Kaposi's sarcoma (KS) as well as primary effusion lymphomas (PEL). The expression of v ... http://www.aegis.com/pubs/aidswkly/2007/aw070211.html File Name: aw070211.html, Size: 10KB, Last Modified: Thursday, May 21, 2009 at 9:26:52 PM |
| 6. |
AEGiS-AIDSWeekly: HIV/AIDS Cancer: Researchers at University of California, Davis Cancer Center target HIV/AIDS cancer (100%) Abstract: New research, "Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP," is the subject of a report. According to recent research from the United States, "The oncogenic herpesvirus, Kaposi's sarcoma-associated herpesvirus, also identified as human herpesvirus 8, contains genes pro ... http://www.aegis.com/pubs/aidswkly/2007/aw070206.html File Name: aw070206.html, Size: 10KB, Last Modified: Thursday, May 21, 2009 at 9:26:52 PM |
| 7. |
AEGiS-AIDSWeekly: HIV/AIDS Cancer: Research from Harvard University provide new insights into HIV/AIDS cancer (100%) Abstract: Data detailed in "Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes" have been presented. According to recent research from the United States, "The Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen ( ... http://www.aegis.com/pubs/aidswkly/2007/aw070115.html File Name: aw070115.html, Size: 10KB, Last Modified: Thursday, May 21, 2009 at 9:26:52 PM |
| 8. |
AEGiS-AIDSWeekly: Studies from Rosalind Franklin University of Medicine and Science update current data on HIV/AIDS cancer (100%) Abstract: Fresh data on hiv/aids cancer are presented in the report "RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. Kaposi's sarcoma-associated herpesvirus (KSHV) (human herpesvirus 8) binds to adherent target cell surface heparan sulfate molecules v ... http://www.aegis.com/pubs/aidswkly/2006/aw061205.html File Name: aw061205.html, Size: 11KB, Last Modified: Thursday, May 21, 2009 at 9:26:51 PM |
| 9. |
AEGiS-AIDSWeekly: HIV/AIDS Cancer: Data from Hospital General Universitario, Internal Medicine Department provide new insights into HIV/AIDS cancer (100%) Abstract: Fresh data on hiv/aids cancer are presented in the report "Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension: A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension. Severe pulmonary hypertension (PH) mimicking idiopathic PH is an increasingly recogn ... http://www.aegis.com/pubs/aidswkly/2006/aw061108.html File Name: aw061108.html, Size: 11KB, Last Modified: Thursday, May 21, 2009 at 9:26:51 PM |
| 10. |
AEGiS-AIDSWeekly: AIDS-Associated Kaposi Sarcoma: AIDS-associated KS prognostic index predicts mortality at initial diagnosis (100%) Abstract: An AIDS-associated Kaposi sarcoma prognostic index predicts mortality during the initial diagnosis. "AIDS-associated Kaposi's sarcoma remains common in individuals with HIV-1 infection in the era of highly active antiretroviral therapy (HAART). We developed a simple model for predicting mortality on the basis of clinic ... http://www.aegis.com/pubs/aidswkly/2006/aw060610.html File Name: aw060610.html, Size: 10KB, Last Modified: Thursday, May 21, 2009 at 9:26:50 PM |
| 11. |
AEGiS-AIDSWeekly: HIV/AIDS-Related Kaposi Sarcoma: Kaposi sarcoma remission associated with HIV suppression and is independent of PI therapy (100%) Abstract: Remission of Kaposi's sarcoma is associated with HIV suppression and is independent of protease inhibitor therapy. According to a recent report from France, "Highly active antiretroviral therapy (HAART) reduces the incidence and improves the prognosis of Kaposi's sarcoma (KS). This study was designed to identify factor ... http://www.aegis.com/pubs/aidswkly/2006/aw060603.html File Name: aw060603.html, Size: 11KB, Last Modified: Thursday, May 21, 2009 at 9:26:50 PM |
| 12. |
AEGiS-AIDSWeekly: AIDS-Related Kaposi Sarcoma: MMP inhibitor COL-3 active and well tolerated in AIDS-related Kaposi sarcoma (100%) Abstract: The matrix metalloproteinases inhibitor COL-3 is active and well tolerated in patients with AIDS-related Kaposi's sarcoma. According to a recently published study from the United States, "Matrix metalloproteinases (MMPs) are involved in tumor metastasis and are overexpressed in Kaposi's sarcoma (KS) cells. ... http://www.aegis.com/pubs/aidswkly/2006/aw060513.html File Name: aw060513.html, Size: 11KB, Last Modified: Thursday, May 21, 2009 at 9:26:49 PM |
| 13. |
AEGiS-AIDSWeekly: AIDS-Related Kaposi Sarcoma: Docetaxel rapidly effective in anthracycline-pretreated AIDS-related KS patients (100%) Abstract: Docetaxel is rapidly effective in anthracycline-pretreated AIDS-related Kaposi's sarcoma patients. "Kaposi's sarcoma (KS) is a potentially life-threatening multifocal neoplasm. Despite the significant decline in the incidence of acquired immune deficiency syndrome (AIDS)-related KS with the use of highly active antiret ... http://www.aegis.com/pubs/aidswkly/2005/aw050707.html File Name: aw050707.html, Size: 10KB, Last Modified: Thursday, May 21, 2009 at 9:26:47 PM |
| 14. |
AEGiS-AIDSWeekly: Kaposi Sarcoma-Associated Herpesvirus: New findings in the area of kaposi sarcoma-associated herpesvirus detailed (100%) Abstract: Data on kaposi sarcoma-associated herpesvirus are outlined in reports from the United States. ... http://www.aegis.com/pubs/aidswkly/2005/aw050404.html File Name: aw050404.html, Size: 17KB, Last Modified: Thursday, May 21, 2009 at 9:26:46 PM |
| 15. |
AEGiS-AIDSWeekly: Kaposi Sarcoma-Associated Herpesvirus: New research in the area of kaposi sarcoma-associated herpesvirus detailed (100%) Abstract: Investigators in the United States have published new kaposi sarcoma-associated herpesvirus data. ... http://www.aegis.com/pubs/aidswkly/2005/aw050301.html File Name: aw050301.html, Size: 17KB, Last Modified: Thursday, May 21, 2009 at 9:26:46 PM |
| 16. |
AEGiS-NV: Cancer facts (100%) Abstract: KAPOSI S sarcoma is a cancer that develops from the cells that line lymph or blood vessels. Medical scientists explain that it is caused by the herpes virus, also called Human Herpes Virus 8. Apparently, people can be infected with this virus, but only develop the disease when their immune system is compromised, common ... http://www.aegis.com/news/nv/2009/nv090514.html File Name: nv090514.html, Size: 7KB, Last Modified: Sunday, May 10, 2009 at 3:00:00 PM |
| 17. |
AEGiS-NV: Kaposi's Sarcoma - Is your immunity strong enough to resist the cancer? (100%) Abstract: WHEN James, 85, went to a clinic after his skin had developed black patches, the doctor referred him to Mulago Hospital to test for kaposi s sarcoma. Kaposi s sarcoma is a type of skin cancer that affects the elderly or any person with a weakened immune system. It is mainly associated with people living with HIV/AIDS. ... http://www.aegis.com/news/nv/2009/nv090517.html File Name: nv090517.html, Size: 14KB, Last Modified: Sunday, May 10, 2009 at 3:00:00 PM |
| 18. |
AEGiS-NV: Mulago researches on best drug (100%) Abstract: RESEARCH on a new drug that can best treat skin cancer is being done by the Infectious Diseases Institute in partnership with Uganda Cancer Institute (IDI). The study started in 2007 and ends in 2012. It is funded by the US National Institute of Health. Dr. Miriam Laker, the coordinator for the antiretroviral for kapos ... http://www.aegis.com/news/nv/2009/nv090516.html File Name: nv090516.html, Size: 8KB, Last Modified: Sunday, May 10, 2009 at 3:00:00 PM |
| 19. |
[O30] AIDS KAPOSI’S SARCOMA: OUTCOMES IN 254 CONSECUTIVE PATIENTS DIAGNOSED IN MODERN TIMES (100%) Abstract: A prospective cohort study was performed to evaluate the clinical outcomes of patients with histologically confirmed AIDS related Kaposi’s sarcoma (KS) diagnosed since the introduction of highly active antiretroviral therapy (HAART). ... http://www.aegis.com/conferences/bhiva/2009/o30.html File Name: o30.html, Size: 5KB, Last Modified: Wednesday, April 01, 2009 at 7:00:01 AM |
| 20. |
[P46] DIAGNOSIS, TREATMENT AND OUTCOMES OF MALIGNANCIES IN HIV IN THE POST-HAART ERA (100%) Abstract: With the advent of HAART, AIDS defining malignancies are becoming less common and outcomes are improving with improved immune function. Poorer outcomes are associated with low CD4 counts and late diagnoses, emphasizing the importance of early diagnosis and treatment with HAART. Non-AIDS defining malignancies are increa ... http://www.aegis.com/conferences/bhiva/2009/p46.html File Name: p46.html, Size: 5KB, Last Modified: Wednesday, April 01, 2009 at 7:00:01 AM |
| 21. |
AEGiS-Health-e: Good Oral health and hygiene lead to better life for HIV patients (100%) Abstract: Going to the dentist is not a pleasurable experience for some. It s even worse for those who are experiencing severe pain from HIV-related oral infections. We take a look at how one s good oral health can deteriorate due to HIV infection. Usually amongst HIV positive people, the first common kind of oral lesions that i ... http://www.aegis.com/news/healthe/2009/he090218.html File Name: he090218.html, Size: 8KB, Last Modified: Saturday, February 28, 2009 at 3:00:00 PM |
| 22. |
(ATN) Kaposi's Sarcoma: New Topical Treatment Approved (100%) Abstract: On February 3 Ligand Pharmaceuticals announced that the FDA had approved Panretin(R) Gel (alitretinoin) for topical treatment of Kaposi s sarcoma; an advisory committee had recommended approval by an 8-1 vote last November. The company has filed for approval in Canada and Europe. Patients apply the gel ... http://www.aegis.com/pubs/atn/1999/atn31301.html File Name: atn31301.html, Size: 8KB, Last Modified: Monday, January 12, 2009 at 9:59:05 PM |
| 23. |
(ATN) Taxol Approved for Kaposi's Sarcoma (100%) Abstract: On August 5 ... http://www.aegis.com/pubs/atn/1997/atn27702.html File Name: atn27702.html, Size: 6KB, Last Modified: Monday, January 12, 2009 at 9:58:37 PM |
| 24. |
(ATN) Kaposi's Sarcoma -- Major Overview Published (100%) Abstract: The KS Project Report: Current Issues in Research & Treatment of Kaposi s Sarcoma , an 85-page report by Michael Marco with Marty Majchrowicz, covers all aspects of conventional treatments, experimental treatments, epidemiology, pathogenesis, and research -- what is being done in KS research, and how its funding an ... http://www.aegis.com/pubs/atn/1994/atn20404.html File Name: atn20404.html, Size: 7KB, Last Modified: Monday, January 12, 2009 at 9:57:45 PM |
| 25. |
(ATN) Kaposi's Sarcoma (KS): Angiogenesis Inhibitors in Early Trials (100%) Abstract: [Note: New York treatment activist Michael Marco heads the Oncology Project of the Treatment Action Group (TAG), which reports on treatments and research for various AIDS-related malignancies, and for Kaposi s sarcoma (KS). He is also co- authoring (with Marty Majchrowicz from AIDS Project Los Angeles) a report on KS p ... http://www.aegis.com/pubs/atn/1994/atn19501.html File Name: atn19501.html, Size: 16KB, Last Modified: Monday, January 12, 2009 at 9:57:39 PM |
| 26. |
AEGiS OI: Kaposi Sarcoma (100%) Abstract: A cancer characterized by numerous bluish-red nodules on the skin, usually on the lower extremities, that is endemic to equatorial Africa and often occurs in a particularly virulent form in people with AIDS. ... http://www.aegis.com/topics/oi/oi-ks.html File Name: oi-ks.html, Size: 6KB, Last Modified: Monday, January 12, 2009 at 9:53:39 PM |
| 27. |
New developments in Kaposi's sarcoma. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 2714. (100%) Abstract: Some of the major findings presented at a National Cancer Institute-sponsored conference on Kaposi s Sarcoma (KS) and its treatment are summarized. KS s clinical features and several potential therapeutic approaches are discussed. Treatment options reviewed include angiogenesis inhibitors; liposomal anthracyclines suc ... http://www.aegis.com/conferences/6/jun/m9660412.html File Name: m9660412.html, Size: 8KB, Last Modified: Thursday, January 08, 2009 at 1:03:45 AM |
| 28. |
Intrathoracic Kaposi's sarcoma: thin CT scans findings (Meeting abstract). (100%) Abstract: Purpose: To describe the thin CT scans findings in AIDS patients with intrathoracic Kaposi s sarcoma (KS). Material and methods: Sixty-one thoracic CT scans of KS were reviewed. The diagnosis of intrathoracic KS was established histologically in 19 patients or on the association of skin KS and the visualization of cha ... http://www.aegis.com/conferences/6/jun/m9660079.html File Name: m9660079.html, Size: 9KB, Last Modified: Thursday, January 08, 2009 at 1:03:19 AM |
| 29. |
Human T-Lymphotrophic Virus Types I/II in autoimmune diseases, growth characteristics and cytokine expression in AIDS-related Kaposi's sarcoma derived cell strains and patients, and constitutive cytokine expression in HTLV and STLV transformed cell lines. (100%) Abstract: Human retroviruses, including Human Immunodeficiency Virus (HIV) and Human T-cell Lymphotrophic Virus Types I and II (HTLV-I/II), have been associated with forms of connective tissue autoimmune diseases including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). These investigations were unable to find ... http://www.aegis.com/conferences/6/jun/m9660071.html File Name: m9660071.html, Size: 11KB, Last Modified: Thursday, January 08, 2009 at 1:03:18 AM |
| 30. |
Expression of transforming growth factor beta and transforming growth factor receptors on AIDS-associated Kaposi's sarcoma. (100%) Abstract: Several humoral growth factors may contribute to the development and growth of AIDS-associated Kaposi s sarcoma (KS). They are either provided by chronically activated cells of the immune system or in an autocrine/paracrine manner by the neoplastic cells themselves. Transforming growth factor beta (TGF-beta) may direc ... http://www.aegis.com/conferences/6/jun/m9660036.html File Name: m9660036.html, Size: 9KB, Last Modified: Thursday, January 08, 2009 at 1:03:16 AM |
|   |
|
|   |
|